Dr. Doncel is the Scientific and Executive Director of CONRAD, a U.S. program focused on developing new technologies in HIV/AIDS prevention and Reproductive Health. CONRAD exists to facilitate the rapid development of safe, acceptable, affordable products and methods that provide contraception and/or prevent the sexual transmission of HIV/AIDS and other infections. Dr. Doncel is also Professor of Obstetrics and Gynecology and directs the Microbicide and Contraceptive Research Laboratory at Eastern Virginia Medical School (EVMS). CONRAD’s R&D activities focus on: i) Preclinical and clinical development of innovative HIV/STI prevention, contraceptive and multipurpose technologies, and ii) Characterization of mucosal factors involved in susceptibility to acquire HIV, and iii) Development of new objective markers of adherence. Dr. Doncel is a translational scientist who received his M.D. degree from the University of Buenos Aires, Argentina, in 1983. After obtaining his Ph.D. degree, he completed a postdoctoral training on reproductive immunology at EVMS under a fellowship of the U.S. Agency for International Development (USAID). He then joined the faculty of EVMS in 1992. Dr. Doncel has authored more than 130 scientific publications in the areas of microbicides, anti-HIV drugs, contraception, sperm biology, pharmacokinetics and reproductive immunology. He is a grant proposal reviewer for national and international organizations such as the National Institute of Allergy and Infectious Diseases (NIAID), the World Health Organization (WHO), the European Community (EC), and the Bill and Melinda Gates Foundation. Dr. Doncel serves as a scientific advisor for various research projects and organizations focused on biomedical HIV prevention efforts and drug development. He is also a member of the WHO Task Force on Hormonal Contraception and HIV-1 infection. He is the principal investigator of ongoing research projects, totaling more than $140M, on women’s health issues related to HIV/STI prevention and family planning.